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Prescription Drug and Substance Abuse in Older Adults- Article
Introduction
Many common medications interact with alcohol, creat-
ing detrimental metabolic (pharmacokinetic) and thera-
peutic (pharmacodynamic) changes (Weathermon & 
Crabb, 1999). Currently, 51% to 78% of aged (50+ 
years) adults are prescribed an alcohol-interactive medi-
cation, the most common being antidepressants, analge-
sics, cardiovascular, central nervous, and metabolic 
agents (Breslow et al., 2015; Weathermon & Crabb, 
1999), with up to 60% taking an alcohol-interactive 
medication and consuming alcohol (Cousins et al., 2014; 
Holton et al., 2017). Yet, no successful interventions are 
being widely implemented, beyond drug labeling, to 
reduce rising alcohol–medication interaction rates in 
aging adults (Castle et al., 2016; Onder et al., 2002; 
Zanjani, Crook, et al., 2016), despite the cost benefits 
seen in educational trials (Bocchi et al., 2018; Haines 
et al., 2013; Harper et al., 2019; Kasteng et al., 2018). 
Knowledge change is focal to educational campaign 
evaluations (Hillsdon et al., 2001), but little information 
is available on knowledge change impact in the area of 
alcohol, aging, and medication safety.
As the older adult alcohol consuming population in the 
United States continues to grow, alcohol use has become 
an increasing public health concern (National Center for 
Chronic Disease Prevention and Health Promotion, 2007). 
Recommended alcohol consumption limits are defined by 
the National Institute on Alcohol Abuse and Alcoholism as 
no more than one drink a day for women of any age and 
men aged 65 years and older (National Institute on Alcohol 
Abuse Alcoholism, 2007). The current prevalence of past-
week alcohol consumption is at 60% and the prevalence of 
drinking more than recommended limits is at 29% among 
older adults aged 50 and older (McEvoy et al., 2013). 
Furthermore, 11% of adults aged 50% to 64% and 7% of 
adults aged 65 and older meet criteria for alcohol use dis-
order (Blazer & Wu, 2011).
What complicates the growing alcohol use in our 
aging adults is that almost 90% of adults aged 60 and 
over take at least one prescription medication, and over 
75% take two or more (Gu et al., 2010; Kantor et al., 
2015). Both acute and chronic alcohol use can modify 
the therapeutic effects of medication by changing the rate 
of absorption as well as changes to the physiological 
responses of organ systems (Chan & Anderson, 2014; 
Moore et al., 2007). In addition, many medications are 
specifically considered to be alcohol-interactive, causing 
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differential medication effects and adverse health conse-
quences (Weathermon & Crabb, 1999). The adverse 
health outcomes related to alcohol–medication interac-
tions can be severe (Blazer & Wu, 2011; Heuberger, 
2009). Consequently, recent studies have also shown 
increases in hospitalizations related to alcohol–medica-
tion interactions among older adults (Castle et al., 2016; 
Zanjani, Smith, et al., 2016).
Given the high and growing prevalence of both alco-
hol consumption and use of medications in older adults, 
risk of experiencing an alcohol–medication interaction 
is high. Brief interventions have been shown to decrease 
harmful alcohol use among older adults (Gordon et al., 
2003; Schonfeld et al., 2010). Despite the overwhelming 
growing risk, there have been limited efforts to widely 
implement community-level educational interventions 
aimed at alcohol–medication risk (AMR; Cain, 1993). 
To address these gaps, this research team developed and 
demonstrated a brief, educational AMR intervention for 
older adults. The aim of the current study is to build on 
prior positive intervention findings (Zanjani et al., 
2018c), by focusing on the older adult alcohol users.
Method
Data Collection
From September 2015 to August 2016, a convenience 
sample of 134 older adults was recruited from four phar-
macies in Virginia. Participants were eligible for the 
study if they were 60 years of age or older. Participants 
took a survey to assess their AMR health behaviors and 
awareness prior to and after exposure to the educational 
materials. In addition to the baseline assessment, a 
3-month assessment was done to examine change over-
time. All participants were contacted a minimum of 4 
times to participate in the follow-up assessment, achiev-
ing a 72% follow-up rate. All study procedures had IRB 
approval, and all participants provided consent prior to 
study participation, described in detail in earlier publica-
tions (Zanjani et al., 2018a, 2018b, 2018c).
The current analysis focused on participants who indi-
cated at baseline that they had consumed alcohol in the 
past month, and were successfully reached for follow-up 
3 months later, making for an analytic sample of n = 40 
participants. Given a focus on 3-month change, particu-
larly in regard to alcohol change, only the baseline (Time 
1) and follow-up (Time 3) data were analyzed. Sixteen 
participants were classified as high-risk drinkers because 
they indicated at baseline that they consumed two or more 
drinks a day, seven or more drinks a week, and/or three or 
more drinks during 1 day in the past 30 days. Five of these 
high-risk drinkers were randomized to pilot brief health 
coaching, of which three participants completed. These 
three participants ranged in age from 68 to 77 and included 
two males and one female.
The analytical sample (n = 40, Table 1) was 
60% female and 100% White, and the majority of 
participants were married or widowed (85%) and had 
completed an associate’s degree or higher (78%). 
Most of the participants were retired (65%) and 
reported a past-year household income of US$50,000 
or more (53%). The sample was relatively healthy at 
baseline, with the majority (63%) reporting no physi-
cal or mental limitations that significantly impeded 
their life activity as well as past 30-day exercise (85%) 
and daily fruit and vegetable intake (95%). Ninety-
five percent of participants reported current medica-
tion use at baseline, putting all but two participants at 
risk for an alcohol–medication interaction. No drink-
ing group differences were found for sample charac-
teristics (Table 1).
An attrition analysis on the 58 older adult drinkers 
at baseline yielded that 3-month assessment comple-
tion was associated with being married (p = .028), 
higher education levels (p = .027), and higher income 
levels (p = .015), confirming the need for the inclusion 
of these demographic variables in analyses as potential 
confounders. When comparing the total sample, with 
the sample that completed the 3-month follow-up 
(n = 40), and the 18 adults that did not complete the 
3-month follow-up, there were differences, indicating 
lower levels of willingness to talk to a doctor 
(p = .013) or friends (p = .46) about alcohol–medica-
tion interactions and willingness to change alcohol 
behaviors (p = .46). There were no identified differ-
ences in drinking levels or baseline knowledge and 
awareness between groups.
Educational Intervention
This brief AMR educational intervention consisted of 
an informational poster, brochure, and 60-s video pub-
lic service announcement, developed by the research 
team (Zanjani, Crook, et al., 2016; Zanjani et al., 2013). 
The feasibility as well as the acceptability of the devel-
oped educational materials were evaluated earlier 
(Zanjani et al., 2018a). The educational materials were 
grounded in the health belief model (Janz & Becker, 
1984; Noar, 2006), and the information–motivation–
behavioral skills (IMB) model (Fisher & Fisher, 2000). 
The educational materials included information about 
AMR and recommendations for visiting the emergency 
room, if someone is experiencing an emergency AMR 
event.
Measures
Behaviors. Participants were asked about their alcohol 
use, and whether they drank more than three alcoholic 
drinks in 1 day during the past 30 days. Participants also 
reported the average number of alcoholic drinks they 
consumed in a typical week in the past 30 days. Also, 
at both time points, participants were asked about the 
frequency in which they talked to their doctor or 
Zanjani et al. 3
Table 1. Baseline Sample Characteristics, by Drinking Status (n = 40).
High-risk drinkers (n = 11) Low-risk drinkers (n = 29)
Sample Characteristics M ± SD M ± SD
Age (59–89) 70.4 ± 5.8 72.8 ± 7.5
 n (%) n (%)
Gender
 Male 7 (63.6) 9 (31.0)
 Female 4 (36.4) 20 (69.0)
Race/ethnicity
 Non-Hispanic White 11 (100.0) 29 (100.0)
 Other race/ethnicity 0 (0.0) 0 (0.0)
Highest level of education
 High school/GED 2 (18.2) 7 (24.1)
 Associate’s degree 2 (18.2) 7 (24.1)
 Bachelor’s degree or higher 7 (63.6) 15 (51.7)
Employment status
 Employed 4 (36.4) 8 (27.6)
 Homemaker 0 (0.0) 1 (3.4)
 Unemployed 0 (0.0) 1 (3.4)
 Retired 7 (63.6) 19 (65.5)
Marital status
 Single, never married 0 (0.0) 1 (3.4)
 Married/domestic partnership 6 (54.5) 18 (62.1)
 Widowed 4 (36.4) 6 (20.7)
 Divorced 1 (9.1) 4 (13.8)
Household income
 Under US$25,000 1 (9.1) 3 (10.3)
 US$25,000– US$49,999 2 (18.2) 4 (13.8)
 US$50,000– US$99,999 3 (27.3) 9 (31.0)
 US$100,000 and above 4 (36.4) 5 (17.2)
 Prefer not to answer 1 (9.1) 8 (27.6)
Current health conditions
 None 0 (0.0) 6 (20.7)
 Only one 3 (27.3) 7 (24.1)
 More than one 8 (72.7) 16 (55.2)
Physical/mental limitations
 None 6 (54.5) 19 (65.5)
 Some 4 (36.4) 8 (27.6)
 Major 1 (9.1) 2 (6.9)
Current medications
 None 0 (0.0) 2 (6.9)
 Over the counter (OTC) only 0 (0.0) 1 (3.4)
 Prescription only 1 (9.1) 9 (31.0)
 Both OTC and prescription 10 (90.9) 17 (58.6)
Past 30 days:
 Exercised 9 (81.8) 25 (86.2)
 Smoked cigarettes 0 (0.0) 5 (17.2)
 Used smokeless tobacco 0 (0.0) 2 (6.9)
 Ate a fruit/vegetable at least once a day 10 (90.9) 28 (96.6)
Medication interactions
 Experienced a prescription drug interaction/adverse medication 
event?
17 (63.6) 16 (55.2)
 Specifically experienced an alcohol and prescription drug interaction? 1 (9.1) 3 (10.3)
 During the past 3 months, experienced a prescription drug 
interaction/adverse medication event?
1 (9.1) 5 (17.2)
 During the past 3 months, experienced an alcohol and prescription 
drug interaction?
0 (0) 0 (0)
Note. Chi-square tests and independent t tests were used to examine the association between sample characteristics and drinking status. No group differences 
were found. GED = general educational development.
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pharmacist about the potential for health events (always, 
occasionally, sometimes, rarely, or never).
Intentions. Participants were asked (yes/maybe, no) 
about their willingness to talk to their doctor about 
AMR, change how much alcohol they consumed to pre-
vent health events, talk to friends and family about risk, 
and be an advocate for safe alcohol and prescription 
drug use. At 3-month follow-up, participants were also 
asked whether they had engaged in these behaviors dur-
ing the last 3 months (yes or no).
Awareness. Participants were asked about medications 
and alcohol that can be used safely together and the safe 
level of alcohol consumption. In addition, participants 
were asked about what medications they believe are 
potentially dangerous when taken with alcohol. A con-
tinuous variable ranging from 0 to 5 was created to rep-
resent the number of potentially dangerous medications 
indicated. Participants were also asked about AMR side 
effects, including vomiting, falls, and shortness of 
breath. A continuous variable ranging from 0 to 17 was 
created to represent the number of side effects indicated. 
Participants were also asked four medication literacy 
dichotomous questions (yes or no).
Statistical Analyses
Analyses were completed using all available data at each 
time point, and descriptive statistics were used to calculate 
the frequencies and means of all variables of interest. To 
examine change from baseline to 3-month follow-up, a 
generalized estimating equations (GEE) approach was 
used. Linear models were fit for variables with a scale 
response, ordinal logistic models were fit for variables 
measured on an ordinal scale, and binary logistic models 
were fit for dichotomous variables. Table 1 shows no char-
acteristic differences between the drinking groups. 
However, gender, marital status, education, and income 
were included as potential confounders in all models, 
given attrition findings and that prior studies have shown 
that male gender (Aira et al., 2005; Barnes et al., 2010; 
McCaul et al., 2010), being married, higher socioeco-
nomic status (Britton & Bell, 2015), and higher education 




There was statistical decline for the mean drinks con-
sumed for high-risk drinkers from 15 drinks to 7 drinks/
week (p < .01). There was no statistically significant 
change from baseline to follow-up in frequency of talk-
ing to a doctor or pharmacist about AMR, drinking dur-
ing the past 30 days, and binge drinking.
Intention
There was no statistically significant change from 
baseline to follow-up in willingness to talk to a health 
professional about AMR, change alcohol consump-
tion to prevent health events, talk to friends and fam-
ily about AMR, or be a community advocate. The 
scores on these items were relatively high at baseline, 
with the majority of participants indicating willing-
ness to talk to a health professional about AMR 
(90%+), change alcohol consumption to decrease 
their risk (90%+), and talk to their friends and family 
about AMR (90%+). At baseline, 80% of participants 
indicated they would be willing to advocate for AMR 
reduction in their communities; however, this signifi-
cantly (p = .048) decreased to 60% of all drinking 
participants at the 3-month follow-up. When partici-
pants were asked on the follow-up assessment whether 
they had performed these behaviors, 20% had spoken 
to a health professional about AMR, 28% had 
changed their alcohol consumption to prevent adverse 
health events, 30% had talked to their friends or fam-
ily about AMR, and 10% acted as a community advo-
cate. No drinking group differences were found for 
intentions.
Awareness
There was a significant increase in the number of iden-
tified AMR side effects and alcohol-interactive medica-
tions among all drinkers (see Table 2). Overall, there 
were significant increases over time in identifying the 
number of potentially dangerous medications when 
mixed with alcohol (p < .001; p = .004) and potential 
side effects (p < .001; p < .001) in all drinkers. There 
was no statistical improvement in medication health 
literacy.
Discussion
The study demonstrated a brief education interven-
tion focused on alcohol–medication interaction risks 
among older adults. In this sample of older adult 
drinkers, the overwhelming majority were currently 
taking both prescription and nonprescription medica-
tions, confirming the need to encourage safe alcohol 
and medication practices. The results of this study 
showed improved elements of AMR behavior and 
awareness over time, with a greater change in high-
risk drinkers.
Between baseline and follow-up, it was encouraging 
that most of the high-risk drinkers indicated that over the 
past 3 months they had changed how much alcohol they 
consumed to prevent adverse health events. Participants 
also noted talking to clinicians, friends, and family about 
AMR. Improvement was also seen over time for identify-
ing potentially dangerous alcohol-interactive medications 
Zanjani et al. 5





 Pre-test Follow-up Pre-test Follow-up
Behaviors
 Talk with your doctor or pharmacist about how alcohol can interact with your prescription medication?
  Always, n (%) 1 (9.1) 2 (18.2) 3 (10.3) 3 (10.3)
  Occasionally, n (%) 1 (9.1) 2 (18.2) 1 (3.4) 3 (10.3)
  Sometimes, n (%) 3 (27.3) 1 (9.1) 10 (34.5) 3 (10.3)
  Rarely, n (%) 4 (36.4) 2 (18.2) 7 (24.1) 8 (27.6)
  Never, n (%) 2 (18.2) 4 (36.4) 8 (27.6) 12 (41.4)
 Drink any alcohol in the past 30 days?  
n (% yes)
11 (100.0) 9 (81.8) 29 (100.0) 27 (93.1)
 Drink more than three alcoholic drinks in 1 day in 
the past 30 days? n (% yes)
6 (54.5) 5 (45.5) 0 (0.0) 1 (3.4)
 Reported number of drinks in a typical week in 
the past 30 days.a,b M (SD)
14.8 ± 17.7 6.7 ± 6.1 3.1 ± 2.4 3.1 ± 2.5
Intentions (% yes)
 Talk to your doctor or pharmacist about AMR? 11 (100.0) 11 (100.0) 26 (89.7) 26 (89.7)
  In the past 3 months, did you talk with your 
doctor or pharmacist about how alcohol can 
interact with your prescription medication?  
n (% yes)
— 4 (36.4) — 4 (13.8)
 Change how much alcohol you consumed to 
prevent AMR?
10 (90.9) 10 (90.9) 26 (89.7) 24 (82.8)
  In the past 3 months, did you change how much 
alcohol you consumed in order to prevent 
harmful prescription drug interactions?c  
n (% yes)
— 6 (54.6) — 5 (17.2)
 Talk to friends and family about AMR? 10 (90.9) 10 (90.9) 28 (96.6) 28 (96.6)
  In the past 3 months, did you to talk to friends 
and family about how alcohol can cause 
harmful prescription drug interactions? 
 n (% yes)
— 3 (27.3) — 9 (31.0)
 Act as a community advocate to reduce AMR?b 10 (90.9) 7 (63.6) 22 (75.9) 17 (58.6)
  In the past 3 months, did you act as a 
community advocate for safe alcohol and 
prescription drug use? n (% yes)
— 1 (9.1) — 3 (10.3)
Awareness (% yes)
 Identify when medications and alcohol can be used safely together?
  Always 0 (0.0) 0 (0.0) 2 (6.9) 1 (3.4)
  Occasionally 0 (0.0) 3 (27.3) 0 (0.0) 1 (3.4)
  Sometimes 7 (63.6) 8 (72.7) 14 (48.3) 13 (44.8)
  Rarely 4 (36.4) 0 (0.0) 9 (31.0) 10 (34.5)
  Never 0 (0.0) 0 (0.0) 4 (13.9) 4 (13.8)
 Identify safe amount of alcohol?
  0 drinks—no alcohol is ever safe 1 (9.1) 1 (9.1) 8 (28.6) 5 (19.2)
  No more than one drink a day 4 (36.4) 5 (45.5) 16 (57.1) 20 (76.9)
  No more than two drinks a day 4 (36.4) 4 (36.4) 4 (14.3) 1 (3.8)
  Three drinks a day or more 2 (18.2) 1 (9.1) 0 (0.0) 0 (0.0)
 Identify alcohol-interactive medications (out of 
5)a,b,d M ± SD
2.5 ± 1.0 3.6 ± 1.4 2.6 ± 1.3 3.6 ± 1.4
 Identify AMR side effects (out of 17)a,b,d M ± SD 10.3 ± 4.1 15.2 ± 1.2 9.7 ± 5.5 14.8 ± 2.4
 Need instructions, pamphlets, or other written 
material from your doctor or pharmacy? n  
(% yes)
3 (27.3) 3 (27.3) 10 (35.4) 9 (31.0)
 (continued)





 Pre-test Follow-up Pre-test Follow-up
 Can name specific drug interactions that your 
medication(s) can have? n (% yes)
6 (54.6) 3 (27.3) 12 (42.9) 10 (34.5)
 Know at least one side effect of each of your 
medication(s)? n (% yes)
9 (81.8) 11 (100.0) 14 (50.0) 22 (75.9)
 Know which of your medication(s) should not be 
taken with alcohol? n (% yes)
7 (63.6) 9 (81.8) 15 (53.6) 21 (72.4)
Note. Analyses were linear, ordinal logistic, and binary logistic GEE models that control for gender, marital status, education, and income.  
AMR = alcohol and medication risk.
aSignificantly different (p < .05) over time among high-risk drinkers. bSignificantly different (p < .05) from pre-test to follow-up among all 
drinkers. cSignificantly different (p < .05) between high-risk and low-risk drinkers. dSignificantly different (p < .05) over time among low-risk 
drinkers.
Table 2. (continued)
and their side effects. This finding was similar to previous 
analyses of older adult drinkers showing a significant 
short-term increase in identifying both the number of 
medications that are potentially dangerous when mixed 
with alcohol and the number of side effects identified 
(Aira et al., 2005).
The findings of this study should be viewed in the 
context of its limitations. The study is limited primarily 
by the small sample size; thus, the study findings need 
to be viewed as preliminary requiring follow-up in 
larger samples for verification. The data also were col-
lected from a single state and the sample was 100% 
non-Hispanic White; therefore, study results may not 
generalize to older adults from other geographic loca-
tions or racial/ethnic backgrounds. In addition, self-
report data are subject to social desirability bias (van 
de Mortel, 2008) and may have led to an underreport-
ing of risky alcohol use behaviors. This study only ana-
lyzed participants who were reached for the 3-month 
follow-up, making the impact on those older adult 
drinkers who did not participate in the follow-up 
assessment (n = 18) unknown, making findings less 
generalizable.
Implications
This study is one of the first brief education interven-
tion demonstration, focused on alcohol–medication 
interaction risk among older adults. The majority of the 
study sample of older adult drinkers was currently tak-
ing both prescription and nonprescription medications, 
confirming the need for behavioral health interventions 
that encourage safe alcohol and medication use. Prior 
analyses have confirmed increased AMR awareness, 
willingness to engage in AMR health behavior change, 
and perceived importance of AMR messaging immedi-
ately post-education exposure. The results of this study 
showed improved AMR awareness over time, and 
decreased drinking levels in drinkers. Future research 
needs to explore individual barriers for adherence and 
enhanced behavioral health interventions that can sus-
tain concomitant alcohol–medication use safety prac-
tices. Future research should examine larger, more 
diverse samples of older adults, including a control 
group comparison. In addition, future work needs 
to consider including more specific tailored guide-
lines for engaging in AMR reduction health behav-
iors, including targeting conversations with a health 
professional about the risk for alcohol–medication 
interactions.
Acknowledgment
Hannah Allen PhD, Pennsylvania State University, made sig-
nificant contributions to this research through her tireless work 
as a graduate assistant on the project. We would like to thank 
Dr. Allen and all study participants and partners throughout 
this study.
Declaration of Conflicting Interests
The authors declared no potential conflicts of interest with 
respect to the research, authorship, and/or publication of this 
article.
Funding
The authors disclosed receipt of the following financial sup-
port for the research, authorship, and/or publication of this 
article: This study was supported by the National Institutes of 
Health (Grant 1K01DA031764).
Ethical Approval
All procedures performed in studies involving human partici-
pants were in accordance with the ethical standards of the 
institutional and/or national research committee and with the 
1964 Helsinki declaration and its later amendments or compa-
rable ethical standards.
Informed Consent
Informed consent was obtained from all individual partici-
pants included in the study.
Zanjani et al. 7
ORCID iD
Faika Zanjani  https://orcid.org/0000-0001-5808-6116
References
Aira, M., Hartikainen, S., & Sulkava, R. (2005). Community 
prevalence of alcohol use and concomitant use of medi-
cation—A source of possible risk in the elderly aged 75 
and older? International Journal of Geriatric Psychiatry, 
20(7), 680–685. https://doi.org/10.1002/gps.1340
Barnes, A. J., Moore, A. A., Xu, H., Ang, A., Tallen, L., Mirkin, 
M., & Ettner, S. L. (2010). Prevalence and correlates of 
at-risk drinking among older adults: The project SHARE 
study. Journal of General Internal Medicine, 25(8), 840–
846. https://doi.org/10.1007/s11606-010-1341-x
Blazer, D. G., & Wu, L. T. (2011). The epidemiology of alco-
hol use disorders and subthreshold dependence in a mid-
dle-aged and elderly community sample. The American 
Journal of Geriatric Psychiatry, 19(8), 685–694. https://
doi.org/10.1097/JGP.0b013e3182006a96
Bocchi, E. A., da Cruz Fá das, D., BrandÃo, S. M., Issa, 
V., Ayub-Ferreira, S. M., la Rocca, H.-P. B., & Wijk, 
S. S. (2018). Cost-effectiveness benefits of a disease 
management program: The REMADHE trial results. 
Journal of Cardiac Failure, 24(10), 627–637. https://doi.
org/10.1016/j.cardfail.2018.04.008
Breslow, R. A., Dong, C., & White, A. (2015). Prevalence of 
alcohol-interactive prescription medication use among 
current drinkers: United States, 1999 to 2010. Alcoholism: 
Clinical and Experimental Research, 39(2), 371–379. 
https://doi.org/10.1111/acer.12633
Britton, A., & Bell, S. (2015). Reasons why people change 
their alcohol consumption in later life: Findings from the 
Whitehall II Cohort Study. PLoS ONE, 10(3), e0119421. 
https://doi.org/10.1371/journal.pone.0119421
Cain, B. R. (1993). The problems of prescription drug 
abuse. The Journal of the South Carolina Medical 
Association, 89(2), 96–97. http://www.ncbi.nlm.nih.gov/
pubmed/8445885
Castle, I. J. P., Dong, C., Haughwout, S. P., & White, A. M. 
(2016). Emergency department visits for adverse drug 
reactions involving alcohol: United States, 2005 to 2011. 
Alcoholism: Clinical and Experimental Research, 40(9), 
1913–1925. https://doi.org/10.1111/acer.13167
Chan, L. N., & Anderson, G. D. (2014). Pharmacokinetic and 
pharmacodynamic drug interactions with ethanol (alco-
hol). Clinical Pharmacokinetics, 53, 1115–1136. https://
doi.org/10.1007/s40262-014-0190-x
Cousins, G., Galvin, R., Flood, M., Kennedy, M. C., 
Motterlini, N., Henman, M. C., . . . Fahey, T. (2014). 
Potential for alcohol and drug interactions in older 
adults: Evidence from the Irish longitudinal study on 
ageing. BMC Geriatrics, 14(1), Article 57. https://doi.
org/10.1186/1471-2318-14-57
Fisher, J. D., & Fisher, W. A. (2000). Theoretical approaches 
to individual-level change in HIV risk behavior. In J. L. 
Peterson & R. J. DiClemente (Eds.), Handbook of HIV 
prevention (pp. 3–55). Kluwer Academic/Plenum Press. 
https://doi.org/10.1007/978-1-4615-4137-0_1
Gordon, A. J., Conigliaro, J., Maisto, S. A., McNeil, M., 
Kraemer, K. L., & Kelley, M. E. (2003). Comparison of 
consumption effects of brief interventions for hazardous 
drinking elderly. Substance Use & Misuse, 38(8), 1017–
1035. http://www.ncbi.nlm.nih.gov/pubmed/12901447
Gu, Q., Dillon, C. F., & Burt, V. L. (2010). Prescription drug 
use continues to increase: U.S. prescription drug data for 
2007-2008. NCHS Data Brief, 42, 1–8. http://www.ncbi.
nlm.nih.gov/pubmed/20854747
Haines, T. P., Hill, A.-M., Hill, K. D., Brauer, S. G., Hoffmann, 
T., Etherton-Beer, C., & McPhail, S. M. (2013). Cost 
effectiveness of patient education for the prevention of 
falls in hospital: Economic evaluation from a randomized 
controlled trial. BMC Medicine, 11, Article 135. https://
doi.org/10.1186/1741-7015-11-135
Harper, K. J., Arendts, G., Geelhoed, E. A., Barton, A. D., & 
Celenza, A. (2019). Cost analysis of a brief intervention for 
the prevention of falls after discharge from an emergency 
department. Journal of Evaluation in Clinical Practice, 
25(2), 244–250. https://doi.org/10.1111/jep.13041
Heuberger, R. A. (2009). Alcohol and the older adult: A com-
prehensive review. Journal of Nutrition for the Elderly, 28, 
203–235. https://doi.org/10.1080/01639360903140106
Hillsdon, M., Cavill, N., Nanchahal, K., Diamond, A., & 
White, I. R. (2001). National level promotion of physical 
activity: Results from England’s ACTIVE for LIFE cam-
paign. Journal of Epidemiology and Community Health, 
55(10), 755–761. https://doi.org/10.1136/jech.55.10.755
Holton, A. E., Gallagher, P., Fahey, T., & Cousins, G. 
(2017). Concurrent use of alcohol interactive medica-
tions and alcohol in older adults: A systematic review 
of prevalence and associated adverse outcomes. BMC 
Geriatrics, 17(1), Article 148. https://doi.org/10.1186/
s12877-017-0532-2
Janz, N. K., & Becker, M. H. (1984). The health belief model: 
A decade later. Health Education & Behavior, 11(1), 1–
47. https://doi.org/10.1177/109019818401100101
Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & 
Giovannucci, E. L. (2015). Trends in prescription drug 
use among adults in the United States from 1999-2012. 
Journal of the American Medical Association, 314(17), 
1818–1831. https://doi.org/10.1001/jama.2015.13766
Kasteng, F., Murray, J., Cousens, S., Sarrassat, S., Steel, J., 
Meda, N., . . . Borghi, J. (2018). Cost-effectiveness and 
economies of scale of a mass radio campaign to promote 
household life-saving practices in Burkina Faso. BMJ 
Global Health, 3(4), e000809. https://doi.org/10.1136/
bmjgh-2018-000809
McCaul, K. A., Almeida, O. P., Hankey, G. J., Jamrozik, K., 
Byles, J. E., & Flicker, L. (2010). Alcohol use and mor-
tality in older men and women. Addiction, 105(8), 1391–
1400. https://doi.org/10.1111/j.1360-0443.2010.02972.x
McEvoy, L. K., Kritz-Silverstein, D., Barrett-Connor, E., 
Bergstrom, J., & Laughlin, G. A. (2013). Changes in alco-
hol intake and their relationship with health status over 
a 24-year follow-up period in community-dwelling older 
adults. Journal of the American Geriatrics Society, 61(8), 
1303–1308. https://doi.org/10.1111/jgs.12366
Moore, A. A., Whiteman, E. J., & Ward, K. T. (2007). Risks 
of combined alcohol-medication use in older adults. 
The American Journal of Geriatric Pharmacotherapy, 
5(1), 64–74. https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC4063202/
National Center for Chronic Disease Prevention and Health 
Promotion. (2007). The state of aging and health in 
8 Gerontology & Geriatric Medicine
America 2007. Aging Health, 3(2), 139–141. https://doi.
org/10.2217/1745509x.3.2.139
National Institute on Alcohol Abuse Alcoholism. (2007). 
Helping patients who drink too much: A clinician’s 
guide (Updated 2005 ed.). National Institute on Alcohol 
Abuse and Alcoholism, National Institutes of Health, U.S. 
Department of Health and Human Services.
Noar, S. M. (2006). A health educator’s guide to theories of 
health behavior. International Quarterly of Community 
Health Education, 24(1), 75–92. https://doi.org/10.2190/
dalp-3f95-gct3-m922
Onder, G., Landi, F., Della Vedova, C., Atkinson, H., 
Pedone, C., Cesari, M., . . . Gambassi, G. (2002). 
Moderate alcohol consumption and adverse drug reac-
tions among older adults. Pharmacoepidemiology and 
Drug Safety, 11(5), 385–392. https://doi.org/10.1002/
pds.721
Schonfeld, L., King-Kallimani, B. L., Duchene, D. M., 
Etheridge, R. L., Herrera, J. R., Barry, K. L., & Lynn, N. 
(2010). Screening and brief intervention for substance 
misuse among older adults: The Florida BRITE project. 
American Journal of Public Health, 100(1), 108–114. 
https://doi.org/10.2105/AJPH.2008.149534
van de Mortel, T. F. (2008). Faking it: Social desirability 
response bias in self-report research. The Australian 
Journal of Advanced Nursing, 25(4), 40–48. http://www.
ajan.com.au/ajan_25.4.html
Weathermon, R., & Crabb, D. W. (1999). Alcohol and medi-
cation interactions. Alcohol Research & Health: The 
Journal of the National Institute on Alcohol Abuse and 
Alcoholism, 23(1), 40–54. http://www.ncbi.nlm.nih.gov/
pubmed/10890797
Zanjani, F., Allen, H. K., Schoenberg, N., Martin, C., & 
Clayton, R. (2018a). Acceptability of intervention mate-
rials to decrease risk for alcohol and medication inter-
actions among older adults. Evaluation and Program 
Planning, 67, 160–166. https://doi.org/10.1016/j.eval-
progplan.2017.12.010
Zanjani, F., Allen, H. K., Schoenberg, N., Martin, C., & 
Clayton, R. (2018b). Immediate effects of a brief inter-
vention to prevent alcohol and medication interactions 
among older adults. Health Education Research, 33(4), 
261–270. https://doi.org/10.1093/her/cyy021
Zanjani, F., Allen, H. K., Schoenberg, N., Martin, C., & 
Clayton, R. (2018c). Sustained intervention effects on 
older adults’ attitudes toward alcohol and medication inter-
actions. American Journal of Health Education, 49(2), 66–
73. https://doi.org/10.1080/19325037.2017.1414641
Zanjani, F., Crook, L., Smith, R., Antimisiaris, D., Schoenberg, 
N., Martin, C., & Clayton, R. (2016). Community phar-
macy staff perceptions on preventing alcohol and medica-
tion interactions in older adults. Journal of the American 
Pharmacists Association, 56(5), 544–548. https://doi.
org/10.1016/j.japh.2016.04.561
Zanjani, F., Hoogland, A. I., & Downer, B. G. (2013). Alcohol 
and prescription drug safety in older adults. Drug, 
Healthcare and Patient Safety, 5(1), 13–27. https://doi.
org/10.2147/DHPS.S38666
Zanjani, F., Smith, R., Slavova, S., Charnigo, R., Schoenberg, 
N., Martin, C., & Clayton, R. (2016). Concurrent alco-
hol and medication poisoning hospital admissions among 
older rural and urban residents. The American Journal of 
Drug and Alcohol Abuse, 42(4), 422–430. https://doi.org/
10.3109/00952990.2016.1154966
